Rigby, M. R., DiMeglio, L. A., Rendell, M. S., Felner, E. I., Dostou, J. M., Gitelman, S. E., . . . Ehlers, M. R. (2013). Targeting effector memory T cells with alefacept in new onset type 1 diabetes: 12 month results from the T1DAL study.
Citación estilo ChicagoRigby, Mark R., et al. Targeting Effector Memory T Cells With Alefacept in New Onset Type 1 Diabetes: 12 Month Results From the T1DAL Study. 2013.
Cita MLARigby, Mark R., et al. Targeting Effector Memory T Cells With Alefacept in New Onset Type 1 Diabetes: 12 Month Results From the T1DAL Study. 2013.
Precaución: Estas citas no son 100% exactas.